- Spotlight Corporate Member of the Month: April 2022 Apr 04 Week 1 (April 4): Eversana EVERSANA™ is the first of our four corporate members to be... read more
- EVERSANA unveils global price and market access solution NAVLIN by EVERSANA Mar 23 Next generation price and market access platform combining data, software and insights into single ecosystem CHICAGO... read more
- EVERSANA’s Data & Analytics Platform ACTICS by EVERSANA Named a 2022 Artificial Intelligence Award Winner Mar 22 CHICAGO – March 22, 2022 – EVERSANA™, the pioneer of next-generation commercial services to the global... read more
- ParcelShield Named a 2022 Best Places to Work Mar 17 ORLANDO, Fla., March 17, 2022— ParcelShield Holdings, LLC (“ParcelShield”) — the leading provider of technology-enabled predictive... read more
- The Value of Embedded Specialty Pharmacists Podcast Episode Feb 16 Listen to the latest NASP Podcast “The Value of Embedded Specialty Pharmacists.” Sheila Arquette, President &... read more
- Evoke Pharma and EVERSANA Extend Commercialization Partnership to Further Support GIMOTI Feb 03 SOLANA BEACH, CA and CHICAGO,IL – Feb 2, 2022 — Evoke Pharma, Inc. (NASDAQ: EVOK), a... read more
- Crawford Thomas Recruiting is Your Hiring Resolution for 2022 Jan 18 Get Candidates Now Connect With Our Team Get Candidates Now ... read more
- OWP Pharmaceuticals and EVERSANA Announce Partnership to Commercialize Oral Liquid Formulations to Treat Neuroscience Disorders Jan 05 CHICAGO — January 5, 2022 — OWP Pharmaceuticals, Inc. is a privately held, neuroscience specialty pharmaceutical... read more
- EVERSANA completes acquisition of Intouch Group, adds the premiere digital-first agency network to the market leader in next generation commercialization Dec 21, 2021 CHICAGO and KANSAS CITY, Mo. — December 21, 2021 — EVERSANA™, the pioneer of next generation... read more
- EVERSANA Announces Real-World Data Agreement with Janssen to Augment Development of Chronic Disease Care Therapies Dec 21, 2021 Analytic work will drive regulatory grade RWD studies and therapeutic evidence to improve patient outcomes CHICAGO... read more